FPH Stock Overview
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Fisher & Paykel Healthcare Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$25.24 |
| 52 Week High | NZ$31.00 |
| 52 Week Low | NZ$18.02 |
| Beta | 0.22 |
| 1 Month Change | 11.68% |
| 3 Month Change | 25.20% |
| 1 Year Change | -9.05% |
| 3 Year Change | 7.82% |
| 5 Year Change | 95.96% |
| Change since IPO | 5,508.89% |
Recent News & Updates
Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)
Jan 23
Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Dec 27Recent updates
Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)
Jan 23Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Dec 27Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Oct 28Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value
Oct 13Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet
Sep 28Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Jul 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
Jul 10Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly
Jun 12A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Apr 17Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger
Apr 04Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Mar 06With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting
Jan 22Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention
Dec 26Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Dec 05This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation
Aug 11Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?
Aug 01Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?
Jul 07Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jun 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
May 01Here's Why We Think Fisher & Paykel Healthcare (NZSE:FPH) Is Well Worth Watching
Mar 28Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 16Have Insiders Been Selling Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares?
Mar 04How Much Is Fisher & Paykel Healthcare's (NZSE:FPH) CEO Getting Paid?
Feb 20Is Weakness In Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 05Are Investors Overlooking Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH)?
Jan 25Did You Participate In Any Of Fisher & Paykel Healthcare's (NZSE:FPH) Incredible 325% Return?
Jan 14Here's What Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shareholder Ownership Structure Looks Like
Jan 03Should You Be Adding Fisher & Paykel Healthcare (NZSE:FPH) To Your Watchlist Today?
Dec 24Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Dec 13Trade Alert: The Independent Chairman Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH), Scott St John, Has Just Spent NZ$51k Buying 7.9% More Shares
Dec 02Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Dec 01How Is Fisher & Paykel Healthcare's (NZSE:FPH) CEO Compensated?
Nov 20Shareholder Returns
| FPH | NZ Medical Equipment | NZ Market | |
|---|---|---|---|
| 7D | -0.4% | -3.1% | 0.5% |
| 1Y | -9.0% | -2.9% | -4.1% |
Return vs Industry: FPH underperformed the NZ Medical Equipment industry which returned -2.9% over the past year.
Return vs Market: FPH underperformed the NZ Market which returned -4.1% over the past year.
Price Volatility
| FPH volatility | |
|---|---|
| FPH Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 9.6% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in NZ Market | 7.3% |
| 10% least volatile stocks in NZ Market | 2.6% |
Stable Share Price: FPH is not significantly more volatile than the rest of NZ stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: FPH's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1934 | 6,788 | Lewis Gradon | https://www.fphcare.com |
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system.
Fisher & Paykel Healthcare Corporation Limited Fundamentals Summary
| FPH fundamental statistics | |
|---|---|
| Market Cap | NZ$14.54b |
| Earnings (TTM) | NZ$251.00m |
| Revenue (TTM) | NZ$1.47b |
58.2x
P/E Ratio9.9x
P/S RatioIs FPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FPH income statement (TTM) | |
|---|---|
| Revenue | NZ$1.47b |
| Cost of Revenue | NZ$574.10m |
| Gross Profit | NZ$898.20m |
| Other Expenses | NZ$647.20m |
| Earnings | NZ$251.00m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.43 |
| Gross Margin | 61.01% |
| Net Profit Margin | 17.05% |
| Debt/Equity Ratio | 7.6% |
How did FPH perform over the long term?
See historical performance and comparison